CYCN
Price
$2.19
Change
-$0.03 (-1.35%)
Updated
Sep 8, 12:13 PM (EDT)
Capitalization
7.1M
GANX
Price
$1.76
Change
-$0.00 (-0.00%)
Updated
Sep 8, 12:54 PM (EDT)
Capitalization
63.27M
60 days until earnings call
Interact to see
Advertisement

CYCN vs GANX

Header iconCYCN vs GANX Comparison
Open Charts CYCN vs GANXBanner chart's image
Cyclerion Therapeutics
Price$2.19
Change-$0.03 (-1.35%)
Volume$595
Capitalization7.1M
Gain Therapeutics
Price$1.76
Change-$0.00 (-0.00%)
Volume$1.2K
Capitalization63.27M
CYCN vs GANX Comparison Chart in %
Loading...
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCN vs. GANX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCN is a Hold and GANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CYCN: $2.22 vs. GANX: $1.76)
Brand notoriety: CYCN and GANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCN: 68% vs. GANX: 133%
Market capitalization -- CYCN: $7.1M vs. GANX: $63.27M
CYCN [@Biotechnology] is valued at $7.1M. GANX’s [@Biotechnology] market capitalization is $63.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCN’s FA Score shows that 1 FA rating(s) are green whileGANX’s FA Score has 0 green FA rating(s).

  • CYCN’s FA Score: 1 green, 4 red.
  • GANX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYCN and GANX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCN’s TA Score shows that 5 TA indicator(s) are bullish while GANX’s TA Score has 4 bullish TA indicator(s).

  • CYCN’s TA Score: 5 bullish, 4 bearish.
  • GANX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CYCN is a better buy in the short-term than GANX.

Price Growth

CYCN (@Biotechnology) experienced а -10.31% price change this week, while GANX (@Biotechnology) price change was -11.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +33.07%.

Reported Earning Dates

GANX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($63.3M) has a higher market cap than CYCN($7.1M). GANX YTD gains are higher at: -18.519 vs. CYCN (-31.202). CYCN has higher annual earnings (EBITDA): -3.76M vs. GANX (-17.16M). GANX has more cash in the bank: 6.69M vs. CYCN (3.01M). CYCN has less debt than GANX: CYCN (0) vs GANX (681K). CYCN has higher revenues than GANX: CYCN (2.17M) vs GANX (0).
CYCNGANXCYCN / GANX
Capitalization7.1M63.3M11%
EBITDA-3.76M-17.16M22%
Gain YTD-31.202-18.519168%
P/E RatioN/AN/A-
Revenue2.17M0-
Total Cash3.01M6.69M45%
Total Debt0681K-
FUNDAMENTALS RATINGS
CYCN: Fundamental Ratings
CYCN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCNGANX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CYCN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMCL28.411.05
+3.84%
Caledonia Mining Corp
CPRX20.290.49
+2.47%
Catalyst Pharmaceuticals
TYGO1.500.03
+2.04%
Tigo Energy
YCBD0.730.01
+1.44%
CBDMD Inc
DPZ463.831.23
+0.27%
Dominos Pizza Inc

CYCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCN has been loosely correlated with JANX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCN jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-7.31%
JANX - CYCN
41%
Loosely correlated
+0.17%
HRTX - CYCN
40%
Loosely correlated
-0.76%
GDTC - CYCN
31%
Poorly correlated
+1.58%
ENTO - CYCN
25%
Poorly correlated
+1.89%
GANX - CYCN
25%
Poorly correlated
+1.15%
More

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+1.15%
COYA - GANX
37%
Loosely correlated
-1.72%
TRDA - GANX
34%
Loosely correlated
+1.34%
EYPT - GANX
33%
Loosely correlated
+17.93%
ELVN - GANX
33%
Loosely correlated
+0.70%
MGTX - GANX
32%
Poorly correlated
-0.39%
More